Responsibility
Learn more about our corporate responsibility mandate.
Global Citizenship
Learn about our efforts, new goals and initiatives in the areas of philanthropy and sustainability.
Research & Development
Explore the latest in R&D news.
Clinical Trial Information
Quick links to helpful resources.

In the News

Sage Therapeutics Stock Forecast, Price & News (NASDAQ:SAGE) - MarketBeat

Google NewsFri, June 5th - 12:51 AM 2015
Does Sage Therapeutics' Failure Predict Its Future Results? - Forbes

Google NewsTue, September 12th - 3:00 AM 2017
Sage Therapeutics drug reduces postpartum depression in two late ... - STAT

Google NewsThu, November 9th - 3:00 AM 2017
Sage triggers another burst of investor enthusiasm as oral depression drug scores in PhII - Endpoints News

Google NewsThu, December 7th - 3:00 AM 2017
Sage Therapeutics wins priority review for intravenous postpartum ... - Mass Device

Google NewsWed, May 30th - 3:00 AM 2018
Sage Therapeutics and Shionogi & Co., Ltd., Enter Strategic ... - Business Wire

Google NewsWed, June 13th - 3:00 AM 2018
Sage Therapeutics Forges $575 Million Deal With Shionogi to ... - BioSpace

Google NewsThu, June 14th - 3:00 AM 2018
About Us - Sage Therapeutics, Inc.

Google NewsSun, June 24th - 12:00 AM 2018
Therapeutic Focus - Sage Therapeutics, Inc.

Google NewsSun, June 24th - 12:01 AM 2018
Terms of Use - Sage Therapeutics, Inc.

Google NewsTue, October 23rd - 3:00 AM 2018
See 90 More

Literature & Journals

Time for fa-la-la with BioWorld’s 10th annual Holiday Gift Guide

BioWorldFri, December 2nd - 2:40 PM 2016
Yes, there’s a doctor in the House (and Senate)

BioWorldTue, January 3rd - 6:21 PM 2017
Is ‘what the patient pays’ the right barometer for pricing drugs?

BioWorldThu, January 26th - 11:08 AM 2017
Myth busters take on drug prices, or do they?

BioWorldMon, March 27th - 5:43 PM 2017
Scientists don’t do politics … until now

BioWorldSun, April 23rd - 6:05 PM 2017
Poverty, politics and preventable disease: Blurring the lines between truth and fiction in BioWorld’s 11th annual Summer Reading List

BioWorldThu, June 1st - 11:13 AM 2017
No choice, no free market

BioWorldTue, June 20th - 1:35 PM 2017
Life and death and #BIO2017

BioWorldMon, June 26th - 5:18 PM 2017
Importation a cliché, not a CAPA

BioWorldFri, August 4th - 6:08 PM 2017
Drug quality from a patient’s perspective

BioWorldSun, September 10th - 9:06 AM 2017
See 90 More

Patents

Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid

CPPTue, October 24th - 5:48 AM 2017
METHODS OF USING (1S, 3S) -3-AMINO-4-DIFLUOROMETHYLENYL-1-CYCLOPENTANOIC ACID

CPPWed, November 22nd - 8:57 AM 2017
FORM 8-K: Adamas Pharmaceuticals Inc FILES Current report

Competitive IntelligenceTue, January 23rd - 12:00 AM 2018
Auris Medical 12.5M share registered direct offering priced at $0.44

Competitive IntelligenceMon, January 29th - 12:00 AM 2018
Auris Medical Announces Pricing of $5.5 Million Registered Direct Offering

Competitive IntelligenceMon, January 29th - 12:00 AM 2018
Auris Medical Holding Ag Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Jan. 16, 2018)

Competitive IntelligenceMon, January 29th - 12:00 AM 2018
NDA for Novel Major Depressive Disorder Treatment Submitted to FDA

Competitive IntelligenceWed, January 31st - 12:00 AM 2018
SEC Filings: Form 6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 01/30/18

Competitive IntelligenceWed, January 31st - 12:00 AM 2018
SEC Filings: Form 424B5: Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 01/29/18

Competitive IntelligenceWed, January 31st - 12:00 AM 2018
SEC Filings: Form 424B3: Form of prospectus reflecting facts events constituting substantive change from last form 01/04/18

Competitive IntelligenceWed, January 31st - 12:00 AM 2018
See 90 More